Charles Robb
2021
In 2021, Charles Robb earned a total compensation of $5.3M as Chief Business Officer and Secretary at Corcept Therapeutics, a 80% increase compared to previous year.
Compensation breakdown
| Bonus | $337,500 |
|---|---|
| Option Awards | $4,357,521 |
| Salary | $562,575 |
| Total | $5,257,596 |
Robb received $4.4M in option awards, accounting for 83% of the total pay in 2021.
Robb also received $337.5K in bonus and $562.6K in salary.
Rankings
In 2021, Charles Robb's compensation ranked 2,470th out of 12,415 executives tracked by ExecPay. In other words, Robb earned more than 80.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,470 out of 12,415 | 80th |
Division Manufacturing | 979 out of 5,501 | 82nd |
Major group Chemicals And Allied Products | 376 out of 2,374 | 84th |
Industry group Drugs | 328 out of 2,095 | 84th |
Industry Pharmaceutical Preparations | 216 out of 1,542 | 86th |
Source: SEC filing on April 25, 2022.
Robb's colleagues
We found four more compensation records of executives who worked with Charles Robb at Corcept Therapeutics in 2021.
News
Corcept Therapeutics CEO Joseph Belanoff's 2021 pay jumps 91% to $11M
April 25, 2022
Corcept Therapeutics CEO Joseph Belanoff's 2020 pay rises 16% to $5.8M
April 22, 2021
Corcept Therapeutics CEO Joseph Belanoff's 2019 pay falls 21% to $5M
April 27, 2020
Corcept Therapeutics CEO Joseph Belanoff's 2018 pay jumps 48% to $6.3M
April 24, 2019